Sentences with phrase «by large drug companies»

-RRB- are contracted out by large drug companies to efficiently and comprehensively perform research on their products and help them bring the drug to market.

Not exact matches

That could help curtail a true drug crisis with devastating economic and social impacts — and which was sparked, in large part, by the actions of huge pharmaceutical companies.

The facility where the investigators had assembled that morning, brandishing an Administrative Inspection Warrant, was a distribution center operated by one of America's largest public companies, the giant drug wholesaler McKesson (mck), which ranks No. 5 on this year's Fortune 500.

The latest pharma innovation report from Deloitte holds some pretty grim news for pharma: returns on R&D investments by large cap companies slid to a mere 3.7 % in 2016, down from the 10.1 % returns seen in 2010 (although the cost of bringing a drug to market is beginning to stabilize).

Acthar reimbursements have been severely restricted by most large pharmaceutical companies and Tricare has discontinued reimbursements for this drug.

Such big winners stopped showing up a few years ago, leaving the large drug companies watching the calendar for the day when earnings would be hurt by the loss of key patent protections.

Stocks of the aforementioned drug companies should be researched for both their takeover potential (specifically INHX, IDIX, and ACHN) by larger companies like Merck, Bristol Myers (BMY) and Johnson & Johnson (JNJ - Free Johnson & Johnson Stock Report).

The value of stock in a multiple sclerosis drug company - which includes large holdings by members of Congress - collapsed Tuesday when company officials announced the drug failed during recent clinical trials.

In the first week of the feature and continuing throughout the month, Next Wave will explore drug discovery opportunities in industry by highlighting the experiences of researchers working for larger and more established companies, as well as the motivations of an individual who chose a drug discovery start - up.

The plan is to predict very early which drugs are likely to succeed and which are not, and promote the winners rapidly to larger (phase III) trials, which most likely would be run by private companies, without data sharing.

Harris cited other examples of concern — a review of 100 studies in the field of psychology in which the findings in only about a third of the studies were reproducible; an effort by scientists at Bayer, another large drug company, that managed to reproduce the findings of only one - quarter of the studies under review; a just - published review of 25 historical candidate genes for schizophrenia which found no evidence that the candidate genes are more associated with the disease than other genes.

THE takeover of the British drugs company Wellcome by its larger rival Glaxo will create a «leaner and fitter» company, but the nation's research effort in pharmaceuticals will suffer, a group of MPs say this week.

By drastically reducing a drug's risk of failure by guiding it to human testing, PharmaStart expects large drug companies to eye such projects more willingly than they would otherwisBy drastically reducing a drug's risk of failure by guiding it to human testing, PharmaStart expects large drug companies to eye such projects more willingly than they would otherwisby guiding it to human testing, PharmaStart expects large drug companies to eye such projects more willingly than they would otherwise.

Pfizer, the world's largest drug company, and one that's proud of its scientific acumen, announced yesterday that it will cut R&D spending in 2012 by about 20 %, from $ 8.5 billion to $ 7 billion.

The test called SkimuneTM, which is trademarked and has a patent pending, has been successfully tested by a number of large pharmaceutical companies on drugs in development and provides a reliable result within two weeks.

Because this idea was so attractive to researchers studying brain diseases, a large number of potential drugs were developed by pharmaceutical companies that block glutamate receptors, including mGluR5.

FDA and FTC Censorship benefits large drug companies by protecting them from competition and destroying innovation.

[Biotechnology Value Fund] believe that AV - 411 is a high risk drug candidate that is best developed (if at all) by a larger company with greater financial resources and a lower cost of capital.

A unique and major move in price, driven by a catalyst like a surprise earnings growth, a drug company's huge, new treatment launch or news that a small company will be acquired by a larger firm